NovAccess Global Inc (CE) (XSNX) Cours

NovAccess Global Inc. is a biopharmaceutical company focused on the development and commercialization of novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We are experts in cutting-edge research involving the use of a patient's own immune system ... NovAccess Global Inc. is a biopharmaceutical company focused on the development and commercialization of novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We are experts in cutting-edge research involving the use of a patient's own immune system to fight cancer. Through our advisory board we have experience successfully executing clinical trials, bringing products to market and increasing the market size of products. Our scientists are well versed in immunology, stem cell biology, neuroscience, molecular biology, imaging, small molecule development and gene therapy as well as other technical assays required for protein and genetic analysis of cancer cells. NovAccess Global is a research and development (R&D) company based in Ohio and California, and our executive management and scientific advisory board have over 15 years of experience in all aspects of biopharmaceutical R&D and commercialization of drug candidates. Show more